News

SIU School of Medicine economic impact adds $1 billion to Illinois

A new report highlights SIU School of Medicine's fiscal impact as one of the top employers in central and southern Illinois.
News

UIS researchers partner with SIU School of Medicine to study how cancer spreads

Scientists at the University of Illinois Springfield and SIU School of Medicine are teaming up to investigate how certain cells in the body connect and encourage the spread of cancer.
News

UIS researchers partner with SIU School of Medicine to study how cancer spreads

Scientists at the University of Illinois Springfield and SIU School of Medicine are teaming up to investigate how certain cells in the body connect and encourage the spread of cancer.
News

Atrium gathering space gets upgrade

The newly renovated atrium in the medical school’s 825 N. Rutledge building offers a welcoming area for students, faculty and staff to meet and interact. SIU alumni Drs. Kathy Bohn, ‘83, and Tom Nielsen, ‘81, made a generous gift to the medical school to refresh the space.
News

Patient Zero-One

The more engineers and scientists learn about AI, the more uses are designed for it. SIU Medicine has recently advanced its problem-based learning curriculum by adding AI-driven patient simulations to years 2 through 4.
News

Patient Zero-One

The more engineers and scientists learn about AI, the more uses are designed for it. SIU Medicine has recently advanced its problem-based learning curriculum by adding AI-driven patient simulations to years 2 through 4.
News

Patient Zero-One

The more engineers and scientists learn about AI, the more uses are designed for it. SIU Medicine has recently advanced its problem-based learning curriculum by adding AI-driven patient simulations to years 2 through 4.
Trial
Neurology

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)

Active not recruiting

The purpose of this study is to assess the effect of BMS-986446 vs placebo on delay of cognitive memory and functional decline in participants (age 50-80) with early Alzheimer's Disease.

Trial
Neurology

A Randomized, Double-blind, Placebo-controlled, Global Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)

Active not recruiting

The purpose of this study is to assess the effect of BMS-986446 vs placebo on delay of cognitive memory and functional decline in participants (age 50-80) with early Alzheimer's Disease.

News

The signs and symptoms of MS

Know the early warning signs of MS Millennials and Gen Zs worry about many things, but at their age, health is often not one of them. At this stage, a tingle there or some fatigue are often brushed aside, but Multiple Sclerosis (MS), a disease that tends to onset between ages 20 and 40, is on the rise globally. Cases are up 30% from 2013 to 2020, with the incidence of MS in women doubling. Early detection is key to successful management of the disease. What is MS? MS is a chronic disease of the central nervous system. It is believed to be an autoimmune disorder where the body mistakenly
Subscribe to